Sunday, February 01, 2015 2:10:31 AM
So #1 on your list was a failure on Buzzy's part. Write him an email and ask for the promised pics.
#2 For the most part he is right. However, what company does anyone own shares of, that the CEO fulfills 100% of what he said he would do? I can't name any.
#3 He said "He Expected". Well, things didn't go as he thought they would. Forecasts and revenue projections are just that. Not promises. And when they are not achieved, they are not lies, just faulty estimates. Even CEO's of DOW companies fall short of yearly revenue estimates. Must we expect more form BUZZY, and OTC CEO?
#4 I think he addressed all that in a recent post here. I'll look back and see if I can find it.
#5 Do you really think a CEO can tell you what the PPS is going to be a year from now? No CEO can do that. No CEO can predict investor sentiment from day to day, let alone a year from now. Not even the CEO of IBM or FORD Motor Company can tell you what the share price of those companies will be a year from now. For all we know the share price could be .10 at the end of 2015. Or it could be .0009.
Are you going to blame BUZZY for the failure of the company he hired to do the CC. Send them an email or call them and voice your complaints. Maybe it will get fixed. How many other OTC companies have a CC every couple of months to keep share holders updated? Or let them ask questions about share structure and convertible debt? Think about that for a minute.
ma6ter, no company is perfect. Not even those listed on the DOW or NASDAQ. And I won't make excuses for the failures of VGID. Just have to take the GOOD with the BAD. Weigh one against the other. And make a decision based on those factors, giving weight to the significance of each positive or negative factor. The rest is up to you. Good Luck
Those that enter with certainty, soon realize doubt; While those that enter with doubt, will discover certainty.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM